Vistagen Therapeutics Inc (VTGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 177 | 176 | 180 | -893 | 310 |
| Gross Profit | 177 | 176 | 180 | -893 | 310 |
| Operating Expenses | 7,175 | 12,415 | 9,946 | 16,597 | 20,083 |
| Operating Income | -6,998 | -12,239 | -9,767 | -17,489 | -19,773 |
| Other Income | 98 | 12 | 5 | 6 | 2 |
| Pre-tax Income | -6,900 | -12,227 | -9,761 | -17,483 | -19,771 |
| Income Tax | 3 | -12 | N/A | N/A | 6 |
| Net Income Continuous | -6,903 | -12,215 | -9,761 | -17,483 | -19,776 |
| Net Income | $-6,903 | $-12,227 | $-9,761 | $-17,483 | $-19,776 |
| EPS Basic Total Ops | -0.94 | -1.68 | -1.42 | -2.54 | -2.87 |
| EPS Basic Continuous Ops | -0.94 | -1.69 | -1.42 | -2.54 | -2.87 |
| EPS Diluted Total Ops | -0.94 | -1.68 | -1.42 | -2.54 | -2.87 |
| EPS Diluted Continuous Ops | -0.94 | -1.69 | -1.42 | -2.54 | -2.87 |
| EBITDA(a) | $-6,966 | $-12,205 | $-9,736 | $-17,456 | $-19,741 |